Potential Role of Navitoclax in Myelofibrosis and T-Cell Acute Lymphoblastic Leukemia
home / news-network / potential-role-of-navitoclax-in-myelofibrosis-and-t-cell-acute-lymphoblastic-leukemia
Expert perspectives on the emerging role of navitoclax, a novel BCL-XL inhibitor, in the treatment armamentarium for myelofibrosis and T-cell acute lymphoblastic leukemia, respectively.